Published on: February 22, 2021
The drug discovery market will expand significantly during the period spanning from 2025 to 2029. The market is catalogued under the pharmaceuticals industry. The report provides a thorough analysis of the market’s growth potential in various regions and key countries, market segmentations, and the effect of new market trends and challenges.
The market is quite competitive. The rise in healthcare expenditure will provide additional growth opportunities and the market’s competitive environment will further intensify.
To help clients improve brand position, the report also provides into the market’s competitive landscape, growth-impacting factors, and vendor strategies.
Our competitive analysis provides insights on the market’s atmosphere and the market share of top companies including:
3M Company
Agilent Technologies Inc
Astrazeneca plc
Boehringer Ingelheim
F Hoffmann-La Roche Ltd
This will help clients plan their market penetration and selling strategies, focus on new growth opportunities, and make other informed business decisions.
The report provides a detailed segmentation analysis of the drug discovery market by type - small molecule drug and biologic drug.
The segmentation analysis covers the factors driving and restricting the market’s growth in these segments, the contribution of this segment to the overall market’s growth, and the individual segments’ size and CAGR year-over-year.
The regional analysis of the drug discovery market forecasts the market’s growth in North America, Europe, APAC, Rest of World (ROW), and Middle East and Africa.
Regional growth analysis covers the market’s growth prospects & challenges in these regions, market size and CAGR, and key markets in these regions.
Moreover, the report also provides a country-level analysis of the market’s growth in these regions and lists out the key countries including -
North America (US, Canada, and Mexico)
Europe (Germany, France, UK, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Australia)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
South America (Brazil, Argentina, Colombia, and Rest of South America)
The drug discovery market report provides a detailed analysis of the key trends and challenges that will highly-impact growth.
The report also discusses the regulatory, technological, and economic trends that affect the market, the major growth drivers, and regional dynamics.
Influenced by the rising demand, the market will witness steady growth during the forecast period.
Rising demand for specialty medicines, one of the significant drug discovery market trends, will have a major influence on the market’s growth. Furthermore, the rise in healthcare expenditure will also influence the demand for drug discovery.
The vendors will also face challenges due to the restricted growth rate due to generic drugs.
What is the current size and growth potential of the drug discovery market?
Who are the key customers and where are they located?
Which product/service segment will have the maximum demand?
What are the implications of the new market trends?
How can vendors innovate their business model to improve their market position in the rapidly changing landscape?
Who are the key competitors?
Should vendors focus on mergers and acquisitions or grow organically?
Need a Regional, Service or Product-specific Analysis to meet your company’s requirements? Customize this report